Virpax Pharmaceuticals In... (VRPX)
undefined
undefined%
At close: undefined
0.36
-11.86%
Pre-market Dec 16, 2024, 07:30 AM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 9.14M 19.00M 36.84M 54.80K 41.54K 48.37K
Short-Term Investments - - - - - -
Long-Term Investments - - - - - -
Other Long-Term Assets - - - 392.34K - -
Receivables - - - - 1.39K -
Inventory - - - - 3.33K -
Other Current Assets 702.98K 678.37K 2.73M 18.27K 3.79K 13.13K
Total Current Assets 9.63M 19.67M 39.57M 73.07K 46.72K 61.50K
Property-Plant & Equipment - - - - - -
Goodwill & Intangibles - - - - - -
Total Long-Term Assets - - - 392.34K - -
Total Assets 9.63M 19.67M 39.57M 465.41K 46.72K 61.50K
Account Payables - 37.64K 19.84K 22.11K 3.50K 6.55K
Deferred Revenue - - - -1.05M -3.5 -6.55K
Short-Term Debt - - - 543.99K 1.26M 500.00K
Other Current Liabilities 7.69M 3.06M 2.06M 3.08M 1.50M 740.21K
Total Current Liabilities 7.69M 3.09M 2.09M 3.66M 2.78M 1.25M
Long-Term Debt - - - 1.02M - -
Other Long-Term Liabilities - - - - - -
Total Long-Term Liabilities - 1.09K - 1.02M - 500.00K
Total Liabilities 7.69M 3.09M 2.09M 4.68M 2.78M 1.25M
Total Debt - - - 1.57M 1.26M 500.00K
Common Stock 12.00 117.00 117.00 31.00 30.00 29.00
Retained Earnings -59.54M -44.35M -22.70M -10.65M -6.31M -3.00M
Comprehensive Income - -0.00 -0.00 - -0.00 -
Shareholders Equity 1.93M 16.58M 37.48M -4.22M -2.73M -1.19M
Total Investments - - - - - -